5 Stocks To Buy That Pay A 5% Dividend Yield

BP plc (LON:BP), Centrica PLC (LON:CNA), GlaxoSmithKline plc (LON:GSK), Royal Dutch Shell Plc (LON:RDSB) and Vodafone Group Plc (LON:VOD) all yield more than 10 times today’s base rate

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I still can’t get over the fact that solid FTSE 100 players like BP (LSE: BP), Centrica (LSE: CNA), GlaxoSmithKline (LSE: GSK), Royal Dutch Shell (LSE: RDSB) and Vodafone (LSE: VOD) all now yield 5% or more… while cash gives savers a near-zero return!

Too many savers fail to realise how much income they could generate by taking a bit of extra risk with their money, plus the scope for capital growth as well. 

So which of these five stocks are your best income options?

BP

The plummeting oil price has hit BP, whose shares are down 12% in just three months. But that’s good news for income seekers, because a lower share price means a higher yield. Today, you get a juicy 5.3%.

This is riskier than leaving your money in the bank, with Deepwater Horizon legal wrangles dragging on interminably, and BP’s 20% stake in Kremlin-controlled oil enterprise Rosneft succumbing to sanctions.

If you can accept these risks, today’s valuation of just 5.6 times earnings may be a good entry point for long-term investors.

Centrica

British Gas owner Centrica offers an even more generous income of 5.8% a year. Again, a falling share price has helped, with the stock down 17% in the last year, over fears that Labour leader Ed Miliband will punish utility companies if he wins next May’s election.

But these fears are priced in, with Centrica trading at 11 times earnings, and its electric income will keep savers warm this winter.

GlaxoSmithKline

Pharmaceutical giant GlaxoSmithKline is yet another FTSE 100 income hero to stumble, its share price down 15% in six months on the Chinese bribery scandal and falling sales.

Today’s price of 12.6 times earnings looks tempting, especially since it secures you an income of 5.5% a year. And there is scope for capital growth, with profits set to flow from its R&D pipeline.

Royal Dutch Shell

Anglo-Dutch oil major Royal Dutch Shell has had a less turbulent year than BP, yet its share price is still down 9% in three months, largely on the oil price slide.

Shell is more expensive than BP, at 14 times earnings, and its dividend is slightly lower at 5%. But it pumps out cash, posting a $6.1bn profit in the second quarter alone, and looks a lot less risky than its rival right now.

Vodafone

Telecommunications giant Vodafone is another UK blue-chip going cheap, down more than 9% in six months. This really is a great time to go shopping for stocks.

Vodafone is throwing off enough cash to splurge $19 billion on its Project Spring revamp, but still has enough left over to pay you a generous income of 5.52% a year.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After falling 32% this stunning FTSE income stock yields 10.2% and I can’t get enough of it

Harvey Jones has taken advantage of the drop in the Phoenix Group Holdings share price to load up on this…

Read more »

Smiling senior white man talking through telephone while using laptop at desk.
Investing Articles

Fancy a near-£2k second income in 2025? Consider these FTSE 100 and FTSE 250 shares

These FTSE 100 and FTSE 250 shares are tipped to provide more market-beating dividends this year by City analysts. Here's…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

2 FTSE dividend stocks I won’t touch with a bargepole in 2025

Two dividend stocks with two big dividend yields. But our writer thinks both FTSE companies could suffer in 2025 as…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Growth Shares

Quantum computing stocks like Rigetti and IonQ are on fire. Should I buy some for my Stocks and Shares ISA?

Quantum computing stocks are very hot right now. Could some exposure turbocharge Edward Sheldon’s Stocks and Shares ISA in 2025?

Read more »

Investing Articles

£5,000 invested in the Nasdaq 100 index at the start of 2023 is now worth…

The Nasdaq 100 index has been on fire over the past couple of years. But this has left it pricey,…

Read more »

Investing Articles

Can the FTSE 100 index hit 10,000 in 2025?

The FTSE 100 hit an all-time high of 8,475 in the first half of 2024. Could the British stock market…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

£10,000 invested in Tesla shares in 2019, would now be worth £128k! But what will happen next?

There’s more to Tesla shares than meets the eye. While we know it as an EV company, Tesla is an…

Read more »

Investing Articles

Investors who bought shares in this under-the-radar UK small-cap a year ago have already doubled their money

Despite Cohort shares more than doubling in the last 12 months, Stephen Wright thinks there could still be more to…

Read more »